How have RGBP shares performed in 2024?

Regen BioPharma's stock was trading at 0.95 at the beginning of 2024. Since then, RGBP shares have decreased by 26.3% and is now trading at 0.70. View the best growth stocks for 2024 here .

Are investors shorting Regen BioPharma?

Regen BioPharma saw a decline in short interest in March. As of March 31st, there was short interest totaling 900 shares, a decline of 76.9% from the March 15th total of 3,900 shares. Based on an average trading volume of 33,300 shares, the short-interest ratio is presently 0.0 days. View Regen BioPharma's Short Interest .

When did Regen BioPharma's stock split?

Regen BioPharma's stock reverse split on the morning of Monday, March 6th 2023. The 1-1500 reverse split was announced on Monday, March 6th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of Regen BioPharma?

Shares of RGBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:RGBP

Regen BioPharma (RGBP) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free RGBP Stock Alerts

0.70

+0.13 (+23.28%)

(As of 09:09 PM ET)

Compare

Today's Range: 0.60
▼
0.70
50-Day Range: 0.57
▼
0.97
52-Week Range: 0.40
▼
2.55

Volume: 10,600 shs
Average Volume: 18,313 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Regen BioPharma alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Regen BioPharma Stock (OTCMKTS:RGBP)

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is involved in the development of its products, and therapies, including HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. The company was incorporated in 2012 and is based in La Mesa, California.

RGBP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RGBP Stock News Headlines

April 3, 2024 | finance.yahoo.com

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

April 2, 2024 | finance.yahoo.com

Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 5, 2024 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

March 1, 2024 | seekingalpha.com

RGBPP Regen BioPharma, Inc. PFD SER A NEW

February 25, 2024 | benzinga.com

Regen BioPharma Stock (OTC:RGBP) Earnings Dates and Earning Calls

February 24, 2024 | benzinga.com

Regen BioPharma Stock (OTC:RGBP), Short Interest Report

February 10, 2024 | msn.com

Regen Biopharma Files Patent for Blood Recovery Treatment

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 5, 2024 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

January 9, 2024 | finance.yahoo.com

Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now

January 8, 2024 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024

December 29, 2023 | bbc.com

Yeovil Refresh team asks for patience over town regeneration

December 5, 2023 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023

November 16, 2023 | finance.yahoo.com

Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments

November 14, 2023 | finance.yahoo.com

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program

October 30, 2023 | finance.yahoo.com

Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023

October 25, 2023 | finance.yahoo.com

Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program

October 18, 2023 | finance.yahoo.com

Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly

October 10, 2023 | finance.yahoo.com

Regen BioPharma, Inc. Receives First Phase of Confirmatory Study

October 4, 2023 | finance.yahoo.com

Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.

October 3, 2023 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on October 5, 2023

September 21, 2023 | barrons.com

Regen BioPharma Inc. Non-Cum. Pfd. Series A

September 19, 2023 | finance.yahoo.com

Studies On Regen BioPharma, Inc.'s DURACAR Indicate Potential Suppression Of Autoimmunity, Company Retains Contract Research Organization To Conduct Additional Confirmatory Studies

September 6, 2023 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023

August 8, 2023 | finance.yahoo.com

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on August 10, 2023

March 23, 2023 | bbc.co.uk

Case study - urban regeneration in Stratford, London

See More Headlines

Receive RGBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:RGBP
CUSIP: N/A
CIK: 1589150
Web: www.regenbiopharmainc.com
Phone: (619) 722-5505
Fax: N/A
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. David Raymond Koos DBA (Age 63)
Ph.D., Chairman, CEO, President, Secretary & Treasurer
Comp: $10.05k

Key Competitors

View All Competitors

RGBP Stock Analysis - Frequently Asked Questions

How have RGBP shares performed in 2024?: Regen BioPharma's stock was trading at 0.95 at the beginning of 2024. Since then, RGBP shares have decreased by 26.3% and is now trading at 0.70.
View the best growth stocks for 2024 here.
Are investors shorting Regen BioPharma?: Regen BioPharma saw a decline in short interest in March. As of March 31st, there was short interest totaling 900 shares, a decline of 76.9% from the March 15th total of 3,900 shares. Based on an average trading volume of 33,300 shares, the short-interest ratio is presently 0.0 days.
View Regen BioPharma's Short Interest.
When did Regen BioPharma's stock split?: Regen BioPharma's stock reverse split on the morning of Monday, March 6th 2023. The 1-1500 reverse split was announced on Monday, March 6th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.
How do I buy shares of Regen BioPharma?: Shares of RGBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RGBP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Regen BioPharma (RGBP) Stock Price, News & Analysis

About Regen BioPharma Stock (OTCMKTS:RGBP)

RGBP Stock Price History

RGBP Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

RGBP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info